位置:首页 > 蛋白库 > HLYC_ECOLX
HLYC_ECOLX
ID   HLYC_ECOLX              Reviewed;         170 AA.
AC   P06736;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1988, sequence version 1.
DT   03-AUG-2022, entry version 87.
DE   RecName: Full=Protein-lysine myristoyltransferase HlyC {ECO:0000305};
DE            EC=2.3.1.- {ECO:0000269|PubMed:11695909, ECO:0000269|PubMed:32461253};
DE   AltName: Full=Hemolysin C;
DE   AltName: Full=Hemolysin-activating lysine-acyltransferase HlyC;
DE   AltName: Full=Toxin-activating protein C, PHLY152;
GN   Name=hlyC {ECO:0000303|PubMed:9521785};
OS   Escherichia coli.
OG   Plasmid IncI2 pHLY152.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=562;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Hess J., Wels W., Vogel M., Goebel W.;
RT   "Nucleotide sequence of a plasmid-encoded hemolysin determinant and its
RT   comparison with a corresponding chromosomal hemolysin sequence.";
RL   FEMS Microbiol. Lett. 34:1-11(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6394952; DOI=10.1007/bf00330963;
RA   Juarez A., Hughes C., Vogel M., Goebel W.;
RT   "Expression and regulation of the plasmid-encoded hemolysin determinant of
RT   Escherichia coli.";
RL   Mol. Gen. Genet. 197:196-203(1984).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2990440; DOI=10.1007/978-1-4613-2447-8_55;
RA   Goebel W., Hacker J., Knapp S., Then I., Wagner W., Hughes C., Juarez A.;
RT   "Structure, function, and regulation of the plasmid-encoded hemolysin
RT   determinant of Escherichia coli.";
RL   Basic Life Sci. 30:791-805(1985).
RN   [4]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=9521785; DOI=10.1021/bi971588y;
RA   Trent M.S., Worsham L.M., Ernst-Fonberg M.L.;
RT   "The biochemistry of hemolysin toxin activation: characterization of HlyC,
RT   an internal protein acyltransferase.";
RL   Biochemistry 37:4644-4652(1998).
RN   [5]
RP   FUNCTION, ACTIVE SITE, AND MUTAGENESIS OF SER-20; HIS-23; CYS-57; SER-58
RP   AND SER-76.
RX   PubMed=10079090; DOI=10.1021/bi982491u;
RA   Trent M.S., Worsham L.M., Ernst-Fonberg M.L.;
RT   "HlyC, the internal protein acyltransferase that activates hemolysin toxin:
RT   role of conserved histidine, serine, and cysteine residues in enzymatic
RT   activity as probed by chemical modification and site-directed
RT   mutagenesis.";
RL   Biochemistry 38:3433-3439(1999).
RN   [6]
RP   MUTAGENESIS OF ARG-24; TYR-70; ARG-87 AND TYR-150.
RX   PubMed=10393560; DOI=10.1021/bi990138y;
RA   Trent M.S., Worsham L.M., Ernst-Fonberg M.L.;
RT   "HlyC, the internal protein acyltransferase that activates hemolysin toxin:
RT   the role of conserved tyrosine and arginine residues in enzymatic activity
RT   as probed by chemical modification and site-directed mutagenesis.";
RL   Biochemistry 38:8831-8838(1999).
RN   [7]
RP   FUNCTION, AND MUTAGENESIS OF GLY-11; PRO-53; GLY-85; ASP-86 AND PRO-96.
RX   PubMed=10413532; DOI=10.1021/bi9905617;
RA   Trent M.S., Worsham L.M., Ernst-Fonberg M.L.;
RT   "HlyC, the internal protein acyltransferase that activates hemolysin toxin:
RT   roles of various conserved residues in enzymatic activity as probed by
RT   site-directed mutagenesis.";
RL   Biochemistry 38:9541-9548(1999).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF 19-SER-SER-20; SER-20;
RP   HIS-23; GLN-43 AND CYS-57.
RX   PubMed=11695909; DOI=10.1021/bi011032h;
RA   Worsham L.M., Trent M.S., Earls L., Jolly C., Ernst-Fonberg M.L.;
RT   "Insights into the catalytic mechanism of HlyC, the internal protein
RT   acyltransferase that activates Escherichia coli hemolysin toxin.";
RL   Biochemistry 40:13607-13616(2001).
RN   [9]
RP   FUNCTION, DEGRADATION, AND MUTAGENESIS OF 128-GLY--VAL-130;
RP   128-GLY-LYS-129; GLY-128 AND LYS-129.
RX   PubMed=11278516; DOI=10.1074/jbc.m009514200;
RA   Guzman-Verri C., Chaves-Olarte E., Garcia F., Arvidson S., Moreno E.;
RT   "In vivo proteolytic degradation of the Escherichia coli acyltransferase
RT   HlyC.";
RL   J. Biol. Chem. 276:16660-16666(2001).
RN   [10]
RP   FUNCTION.
RX   PubMed=15065878; DOI=10.1021/bi035919k;
RA   Langston K.G., Worsham L.M., Earls L., Ernst-Fonberg M.L.;
RT   "Activation of hemolysin toxin: relationship between two internal protein
RT   sites of acylation.";
RL   Biochemistry 43:4338-4346(2004).
RN   [11]
RP   FUNCTION, ACTIVITY REGULATION, HEME-BINDING, AND MUTAGENESIS OF
RP   151-HIS-HIS-152.
RX   PubMed=29908817; DOI=10.1016/j.bbagen.2018.06.012;
RA   Peherstorfer S., Brewitz H.H., Paul George A.A., Wissbrock A., Adam J.M.,
RA   Schmitt L., Imhof D.;
RT   "Insights into mechanism and functional consequences of heme binding to
RT   hemolysin-activating lysine acyltransferase HlyC from Escherichia coli.";
RL   Biochim. Biophys. Acta 1862:1964-1972(2018).
RN   [12]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=32461253; DOI=10.1074/jbc.ra120.014122;
RA   Osickova A., Khaliq H., Masin J., Jurnecka D., Sukova A., Fiser R.,
RA   Holubova J., Stanek O., Sebo P., Osicka R.;
RT   "Acyltransferase-mediated selection of the length of the fatty acyl chain
RT   and of the acylation site governs activation of bacterial RTX toxins.";
RL   J. Biol. Chem. 295:9268-9280(2020).
CC   -!- FUNCTION: Protein-lysine myristoyltransferase that catalyzes
CC       myristoylation of the protoxin (HlyA) at two internal lysine residues,
CC       thereby converting it to the active toxin.
CC       {ECO:0000269|PubMed:10079090, ECO:0000269|PubMed:10413532,
CC       ECO:0000269|PubMed:11278516, ECO:0000269|PubMed:11695909,
CC       ECO:0000269|PubMed:15065878, ECO:0000269|PubMed:29908817,
CC       ECO:0000269|PubMed:32461253, ECO:0000269|PubMed:9521785}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-lysyl-[protein] + tetradecanoyl-[ACP] = H(+) + holo-[ACP] +
CC         N(6)-tetradecanoyl-L-lysyl-[protein]; Xref=Rhea:RHEA:70611,
CC         Rhea:RHEA-COMP:9648, Rhea:RHEA-COMP:9685, Rhea:RHEA-COMP:9752,
CC         Rhea:RHEA-COMP:15437, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969,
CC         ChEBI:CHEBI:64479, ChEBI:CHEBI:78477, ChEBI:CHEBI:141129;
CC         Evidence={ECO:0000269|PubMed:11695909, ECO:0000269|PubMed:32461253};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70612;
CC         Evidence={ECO:0000269|PubMed:11695909, ECO:0000269|PubMed:32461253};
CC   -!- ACTIVITY REGULATION: The acyltransferase activity is inhibited by heme.
CC       {ECO:0000269|PubMed:29908817}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.6 uM for tetradecanoyl-CoA {ECO:0000269|PubMed:11695909};
CC         KM=3.6 uM for HlyA peptide {ECO:0000269|PubMed:11695909};
CC         Vmax=4667 pmol/min/mg enzyme {ECO:0000269|PubMed:11695909};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:9521785}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.
CC   -!- PTM: Proteolytically cleaved by the protease systems ClpAP, ClpXP and
CC       FtsH, leading to its degradation. {ECO:0000269|PubMed:11278516}.
CC   -!- SIMILARITY: Belongs to the RTX toxin acyltransferase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M14107; AAA98232.1; -; Genomic_DNA.
DR   EMBL; X01072; CAA25535.1; -; Genomic_DNA.
DR   EMBL; M35668; AAA23980.1; -; Genomic_DNA.
DR   PIR; I41288; I41288.
DR   RefSeq; WP_001372478.1; NZ_SVID01000104.1.
DR   AlphaFoldDB; P06736; -.
DR   SMR; P06736; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0020037; F:heme binding; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0018030; F:peptidyl-lysine N6-myristoyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0044179; P:hemolysis in another organism; IEA:UniProtKB-KW.
DR   GO; GO:0009404; P:toxin metabolic process; IEA:InterPro.
DR   InterPro; IPR003996; RTX_toxin-activating_protC_bac.
DR   Pfam; PF02794; HlyC; 1.
DR   PRINTS; PR01489; RTXTOXINC.
PE   1: Evidence at protein level;
KW   Acyltransferase; Cytolysis; Cytoplasm; Heme; Hemolysis; Iron;
KW   Metal-binding; Plasmid; Transferase; Virulence.
FT   CHAIN           1..170
FT                   /note="Protein-lysine myristoyltransferase HlyC"
FT                   /id="PRO_0000217875"
FT   ACT_SITE        23
FT                   /evidence="ECO:0000305|PubMed:10079090"
FT   ACT_SITE        92
FT                   /evidence="ECO:0000250|UniProtKB:P55132"
FT   BINDING         151
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /evidence="ECO:0000305|PubMed:29908817"
FT   MUTAGEN         11
FT                   /note="G->A: Strongly decreased acyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:10413532"
FT   MUTAGEN         19..20
FT                   /note="SS->AA: Significant loss of acyltransferase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:11695909"
FT   MUTAGEN         20
FT                   /note="S->A,C,T,H: Significant loss of acyltransferase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:10079090,
FT                   ECO:0000269|PubMed:11695909"
FT   MUTAGEN         23
FT                   /note="H->A,C,S,D,K,Y: Complete loss of acyltransferase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:10079090,
FT                   ECO:0000269|PubMed:11695909"
FT   MUTAGEN         24
FT                   /note="R->A,K: Little effect."
FT                   /evidence="ECO:0000269|PubMed:10393560"
FT   MUTAGEN         43
FT                   /note="Q->A: Decreased acyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:11695909"
FT   MUTAGEN         53
FT                   /note="P->A: Strongly decreased acyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:10413532"
FT   MUTAGEN         57
FT                   /note="C->A: Does not affect acyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:10079090,
FT                   ECO:0000269|PubMed:11695909"
FT   MUTAGEN         58
FT                   /note="S->A: Little effect."
FT                   /evidence="ECO:0000269|PubMed:10079090"
FT   MUTAGEN         70
FT                   /note="Y->F: No effect."
FT                   /evidence="ECO:0000269|PubMed:10393560"
FT   MUTAGEN         70
FT                   /note="Y->G: Strongly decreased acyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:10393560"
FT   MUTAGEN         76
FT                   /note="S->A: Slightly decreased acyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:10079090"
FT   MUTAGEN         85
FT                   /note="G->A: Abolished acyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:10413532"
FT   MUTAGEN         86
FT                   /note="D->A: Decreased acyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:10413532"
FT   MUTAGEN         87
FT                   /note="R->A,K: Little effect."
FT                   /evidence="ECO:0000269|PubMed:10393560"
FT   MUTAGEN         96
FT                   /note="P->A: Strongly decreased acyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:10413532"
FT   MUTAGEN         128..130
FT                   /note="Missing: Abolished ability to activate HlyA. Does
FT                   not affect protein stability."
FT                   /evidence="ECO:0000269|PubMed:11278516"
FT   MUTAGEN         128..129
FT                   /note="GK->VI: Abolished ability to activate HlyA. Does not
FT                   affect protein stability."
FT                   /evidence="ECO:0000269|PubMed:11278516"
FT   MUTAGEN         128
FT                   /note="G->V: Abolished ability to activate HlyA. Does not
FT                   affect protein stability."
FT                   /evidence="ECO:0000269|PubMed:11278516"
FT   MUTAGEN         129
FT                   /note="K->I: Reduced ability to activate HlyA."
FT                   /evidence="ECO:0000269|PubMed:11278516"
FT   MUTAGEN         150
FT                   /note="Y->F: No effect."
FT                   /evidence="ECO:0000269|PubMed:10393560"
FT   MUTAGEN         150
FT                   /note="Y->G: Great loss of activity."
FT                   /evidence="ECO:0000269|PubMed:10393560"
FT   MUTAGEN         151..152
FT                   /note="HH->AA: Abolished heme-binding."
FT                   /evidence="ECO:0000269|PubMed:29908817"
SQ   SEQUENCE   170 AA;  19770 MW;  754DB786609734EF CRC64;
     MNINKPLEIL GHVSWLWASS PLHRNWPVSL FAINVLPAIQ ANQYVLLTRD DYPVAYCSWA
     NLSLENEIKY LNDVTSLVAE DWTSGDRKWF IDWIAPFGDN GALYKYMRKK FPDELFRAIR
     VDPKTHVGKV SEFHGGKIDK QLANKIFKQY HHELITEVKR KSDFNFSLTG
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024